Beijing Advaccine Biotechnology has raised 200 million yuan ($29 million) in a Series B round funding from MatrixPartners, Star Capital, and others, while Baidu’s Smart Living Group (SLG) has secured an undisclosed Series A from Baidu, CPE, and IDG.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
